Wearable cardioverter ‐defibrillator: friend or foe in suspected myocarditis?

ConclusionsOur data suggest that myocarditis patients may benefit from WCD therapy. However, as our study is not powered for outcome, further randomized studies powered for the outcome morbidity and mortality are necessary.

Source: ESC Heart Failure - May 1, 2021 Category: Cardiology Authors: Florian Blaschke, Philipp Lacour, Phi Long Dang, Abdul Shokor Parwani, Felix Hohendanner, Thula Walter, Karin Klingel, Uwe K ühl, Frank R. Heinzel, Mohammad Sherif, Leif‐Hendrik Boldt, Burkert Pieske, Carsten Tschöpe Tags: Short Communication Source Type: research